Drug Trial Radar · NCT02385097
Chloroprocaine 2% vs Ropivacaine 0.75% in Ultrasound-guided Axillary Nerve Block
Last checked: Nov 20, 2026Latest source record: Jul 15, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
211
Actual
Start
Apr 2015
Primary completion
May 2017
Study completion May 2017
Sponsor
- Lead sponsor
- Sintetica SAIndustry
- Sponsor type
- Industry
- Collaborators
- Cross S.A.
- First posted
- Mar 11, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Other
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The Study evaluate the non-inferiority of Test product (Chloroprocaine 2%) versus Reference product (Ropivacaine 0.75%) in terms of proportion of subjects with a successful block for distal upper limb surgeries Successful block: anaesthesia adequate for the surgery without any supplementation in the first 45 min.
Conditions
- Axillary Nerve Block
Interventions
Chloroprocaine HCl 2%Drug
Single Administration (20mL) by Axillary Nerve Route
Ropivacaine 0.75%Drug
Single Administration (20mL) by Axillary Nerve Route
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Successful Block for Distal Upper Limb SurgeriesTime frame: 45 min from the time of readiness of surgery
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Claudio Camponovo
Gravesano, Lugano, Switzerland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.